Angiotensin receptor blockers and heart failure: still CHARMing after VALIANT?

Eur Heart J. 2004 Mar;25(5):357-8. doi: 10.1016/j.ehj.2003.12.023.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Benzimidazoles / therapeutic use
  • Biphenyl Compounds
  • Chronic Disease
  • Heart Failure / drug therapy*
  • Humans
  • Myocardial Infarction / drug therapy*
  • Randomized Controlled Trials as Topic
  • Tetrazoles / therapeutic use
  • Valine / analogs & derivatives
  • Valine / therapeutic use
  • Valsartan

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Benzimidazoles
  • Biphenyl Compounds
  • Tetrazoles
  • Valsartan
  • Valine
  • candesartan